Impedimed Quote - IPD

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.052

Bid

0.052

Ask

0.053

Volume

728,322

0.051 Day's Range 0.053

0.042 52 Week Range 0.16

Market Cap

105.201M

Previous Close

0.051

Open

0.052

Last Trade

8992

0.053

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,073,039

Shares Outstanding

2,023,093,918

Dividend Yield

PE Ratio

-5.10

Earnings Per Share (EPS)

-0.01

Revenue

13.13M

Net Profit

-19.79M

Sector

Electromedical Apparatus

Industry

Electromedical Apparatus

Website

investors.impedimed.com/financials/annual-reports

Headquarters

Brisbane, Queensland, Aus

Founded

Impedimed Limited is listed in the Electromedical Apparatus sector of the Australian Stock Exchange with ticker IPD. The last closing price for Impedimed was AUD0.05. Over the last year, Impedimed shares have traded in a share price range of AUD 0.042 to AUD 0.16.

Impedimed currently has 2,023,093,918 shares outstanding. The market capitalization of Impedimed is AUD103.18 million. Impedimed has a price to earnings ratio (PE ratio) of -5.10.

ImpediMed Announces PREVENT Interim Results – “Practice-Changing”

Following >1,100 breast cancer survivors, PREVENT is the largest, multi-site randomized controlled trial (RCT) ever performed to study lymphedema prevention ImpediMed Limited...

ImpediMed to Become Business Associate-Compliant with Launch of Third-Generation SOZO® Software

ImpediMed Limited (ASX:IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy...

ImpediMed Announces PREVENT Trial Accepted for Publication & Presentation at the 2019 Annual Meeting of the American Society ...

Largest prospective, multi-center, randomized trial undertaken in the prevention of breast cancer-related lymphedema ImpediMed Limited (ASX:IPD), a global provider of medical technology...

March is Lymphedema Awareness Month: ImpediMed Kicks Off Support on World Lymphedema Day, March 6; Co-sponsors Reception Feat...

Joins with medi, makers of compression products, to co-sponsor an invite-only reception “starring” Academy Award winner Kathy Bates, March 28 Supports Lymphatic Education &...

Early Surveillance with L-Dex® Reduces Incidence, Severity & Cost of Breast Cancer-Related Lymphedema, ImpediMed Reports Pub...

ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy...

ImpediMed’s SOZO® Digital Health Platform Captures First Place in 19th Innovations in Healthcare™ ABBY Award

Richard Carreon, managing director and CEO, accepts prestigious honor ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage...

ImpediMed Highlights Publication of Recommendations in New England Journal of Medicine: Supports Use of Bioimpedence & L-Dex ...

International authority on lymphedema, Stanley G. Rockson, M.D., calls for use of Bioimpedance Spectroscopy as protocol in surveillance and assessment of cancer survivors Growing body...

ImpediMed’s SOZO® Digital Health Platform Voted Among Top Five Finalists for Southern California ABBY Awards

Richard Carreon, managing director and CEO, to present at 19th Innovations in Healthcare Awards, Dec. 5, 2018, Long Beach Airport Marriott Hotel ImpediMed Limited (ASX: IPD), a...

MD Anderson Study Uses ImpediMed L-Dex Bioimpedance Spectroscopy to Assess Correlation with Limb Volume, Lymphatic Function i...

Study concludes L-Dex correlates most closely with all measures and is the recommended metric when using BIS Publication of a new study to assess the validity of L-Dex bioimpedance...

ImpediMed Announces First Patient Enrolled at Scripps Memorial Hospital in 200-Patient Heart Failure Trial

ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.001	1.96078431373	0.051	0.053	0.051	283250	0.05170459	DE
4	0	0	0.052	0.06	0.049	979021	0.05345053	DE
12	-0.009	-14.7540983607	0.061	0.068	0.048	1073039	0.05558404	DE
26	-0.019	-26.7605633803	0.071	0.071	0.042	1647658	0.0556196	DE
52	-0.098	-65.3333333333	0.15	0.16	0.042	2130926	0.07716339	DE
156	-0.118	-69.4117647059	0.17	0.24	0.042	2442199	0.11833955	DE
260	-0.103	-66.4516129032	0.155	0.24	0.032	2611601	0.11313614	DE

IPD - Frequently Asked Questions (FAQ)

What is the current Impedimed share price?

The current share price of Impedimed is AUD 0.052

How many Impedimed shares are in issue?

Impedimed has 2,023,093,918 shares in issue

What is the market cap of Impedimed?

The market capitalisation of Impedimed is AUD 103.18M

What is the 1 year trading range for Impedimed share price?

Impedimed has traded in the range of AUD 0.042 to AUD 0.16 during the past year

What is the PE ratio of Impedimed?

The price to earnings ratio of Impedimed is -5.1

What is the cash to sales ratio of Impedimed?

The cash to sales ratio of Impedimed is 7.69

What is the reporting currency for Impedimed?

Impedimed reports financial results in AUD

What is the latest annual turnover for Impedimed?

The latest annual turnover of Impedimed is AUD 13.13M

What is the latest annual profit for Impedimed?

The latest annual profit of Impedimed is AUD -19.79M

What is the registered address of Impedimed?

The registered address for Impedimed is UNIT 1, 50 PARKER COURT, BRISBANE, QUEENSLAND, 4008

What is the Impedimed website address?

The website address for Impedimed is investors.impedimed.com/financials/annual-reports

Which industry sector does Impedimed operate in?

Impedimed operates in the ELECTROMEDICAL APPARATUS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EM2REagle Mountain Mining Limited	AUD 0.002 (100.00%)	1M
AAUOAntilles Gold Limited	AUD 0.002 (100.00%)	500k
NFLONorfolk Metals Ltd	AUD 0.03 (50.00%)	1.23k
DXBODimerix Limited	AUD 0.345 (50.00%)	833.41k
RGTArgent Biopharma Ltd	AUD 0.25 (47.06%)	335.35k
SPAOSpacetalk Ltd	AUD 0.001 (-66.67%)	1
OSLOBOncoSil Medical Ltd	AUD 0.001 (-50.00%)	840k
NAENew Age Exploration Limited	AUD 0.003 (-25.00%)	195.67k
EXLOElixinol Wellness Limited	AUD 0.003 (-25.00%)	120.37k
GMNGold Mountain Limited	AUD 0.003 (-25.00%)	1.39M
ROGRed Sky Energy Limited	AUD 0.006 (-20.00%)	54.97M
TMGTrigg Minerals Ltd	AUD 0.048 (11.63%)	50.62M
BRNBrainchip Holdings Ltd	AUD 0.35 (-5.41%)	48.85M
GCMGreen Critical Minerals Ltd	AUD 0.019 (15.15%)	42.09M
SYASayona Mining Limited	AUD 0.0275 (1.85%)	35.13M